Search

Your search keyword '"Frausini, G."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Frausini, G." Remove constraint Author: "Frausini, G."
35 results on '"Frausini, G."'

Search Results

1. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

2. Multicenter validation of the DETAIL questionnaire for the screening of spondyloarthritis in patients with inflammatory bowel diseases

3. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

4. Tocilizumab in COVID‐19 interstitial pneumonia

5. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

6. The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry

7. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry

8. High vs. low doses of low‐molecular‐weight heparin for the treatment of superficial vein thrombosis of the legs: a double‐blind, randomized trial

9. Aspirin for preventing the recurrence of venous thromboembolism

10. Aspirin for Preventing the Recurrence of Venous Thromboembolism

11. MEDICAL SCIENCE. GISSI-2: A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12 490 patients with acute myocardial infarction

14. DETERMINANTS OF 6-MONTH MORTALITY IN SURVIVORS OF MYOCARDIAL-INFARCTION AFTER THROMBOLYSIS - RESULTS OF THE GISSI-2 DATA-BASE

15. Discharge from the emergency department and early hospital revaluation in patients with COVID-19 pneumonia: a prospective study.

16. Safety of intermediate dose of low molecular weight heparin in COVID-19 patients.

17. Olfactory Dysfunction in COVID-19 Patients: Prevalence and Prognosis for Recovering Sense of Smell.

18. Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study.

19. Successful recovery from COVID-19 pneumonia after receiving baricitinib, tocilizumab, and remdesivir. A case report: Review of treatments and clinical role of computed tomography analysis.

20. [Peripheral vascular damage in hypertension].

21. Diuresis and intensive saluresis.

22. [The treatment of refractory hyperlipoproteinemias].

23. [A large case load of patients with dyslipidemia: effects of treatment with deae-dextran].

24. [Cellular water-electrolyte equilibrium in edema and changes induced by diuretics].

26. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].

27. [Intensive saluresis].

28. [Hemodynamic effects of diuretics].

29. [Clinical program of therapy for ascitic edema in liver disease].

30. [Negative effects of diuretics].

31. [Diuretics in the therapy of arterial hypertension].

32. [Indications for therapy with diuretics].

33. [Diuretics].

34. [Physiopathology of the body fluids].

35. [Clinical pharmacology of vasoactive substances: study on pentoxifylline].

Catalog

Books, media, physical & digital resources